Vaxart to Host Stockholder Fireside Chat on May 8 at 4:30 p.m. ET
Vaxart (OTCQX: VXRT) will host a virtual stockholder fireside chat on May 8, 2026 at 4:30 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Vaxart (OTCQX: VXRT) will host a virtual stockholder fireside chat on May 8, 2026 at 4:30 p.m. ET. Management will answer shareholder questions. The company will report Q1 2026 financial results after market close on May 7, 2026. A live webcast and replay will be available at the company website.
Key Figures
- Q1 2026 results date
- May 7, 2026
- Company plans to report Q1 2026 financial results after market close
- Fireside chat date
- May 8, 2026
- Virtual stockholder fireside chat at 4:30 p.m. ET / 1:30 p.m. PT
- Shelf capacity
- $300,000,000
- Aggregate amount of securities registered under S-3 shelf filed Apr 15, 2026
- ATM allocation
- $49,772,479
- Common stock capacity under at-the-market Sales Agreement within shelf
- Shares outstanding
- 241,414,053
- Common shares outstanding as reported in S-3 prospectus
- Reference share price
- $0.63
- Closing price on April 10, 2026 cited in S-3 prospectus
- Current price
- $0.77
- Pre-news price with 24h change of 1.81%
- 52-week range
- $0.2606–$0.8449
- Current price is -8.86% below 52-week high, 195.47% above low
Historical Context
-
New independent director with over 35 years of biopharma experience appointed.
-
Share purchase agreement enabling up to $25M common stock sales over 24 months.
-
Reported 2025 results with revenue, net income, cash runway and pipeline updates.
-
Announced business update call and stockholder fireside chat webcasts in March.
-
Planned presentation at Oppenheimer healthcare conference with webcast access.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Company to report first quarter 2026 financial results on May 7
SOUTH SAN FRANCISCO, Calif., May 01, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) today announced that members of the Company’s senior management team will participate in a virtual fireside chat on Friday, May 8, 2026 at 4:30 p.m. ET / 1:30 p.m. PT as part of its regular series to answer frequently asked questions from its stockholders. The Company plans to report financial results for the first quarter ended March 31, 2026, after the market close on Thursday, May 7, 2026.
The live fireside chat can be accessed by clicking here or on the Company’s website at www.vaxart.com.
Investors may submit written questions in advance of the conference call to ir@vaxart.com or through the webcast portal.
A replay of the fireside chat webcast will be available on the Company’s website at www.vaxart.com following the conclusion of the event.
About Vaxart
Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart believes that its proprietary pill vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Vaxart’s development programs currently include pill vaccines designed to protect against coronavirus, norovirus and influenza, as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart’s first immune-oncology indication. Vaxart has filed broad domestic and international patent applications covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.
Contact
Vaxart Media and Investor Relations:
FINN Partners
IR@vaxart.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.